BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Casamayor M, Morlock R, Maeda H, Ajani J. Targeted literature review of the global burden of gastric cancer. Ecancermedicalscience. 2018;12:883. [PMID: 30679950 DOI: 10.3332/ecancer.2018.883] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Martín-Richard M, Carmona-Bayonas A, Custodio AB, Gallego J, Jiménez-Fonseca P, Reina JJ, Richart P, Rivera F, Alsina M, Sastre J. SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019). Clin Transl Oncol 2020;22:236-44. [PMID: 31989475 DOI: 10.1007/s12094-019-02259-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
2 Xin F, Mzee SAS, Botwe G, He H, Zhiyu S, Gong C, Said ST, Jixing C. Short-term evaluation of immune levels and nutritional values of EN versus PN in gastric cancer: a systematic review and a meta-analysis. World J Surg Oncol 2019;17:114. [PMID: 31269969 DOI: 10.1186/s12957-019-1658-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
3 Li J, Su T, Yang L, Deng L, Zhang C, He Y. High SLC17A9 expression correlates with poor survival in gastric carcinoma. Future Oncology 2019;15:4155-66. [DOI: 10.2217/fon-2019-0283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
4 Aftabi Y, Soleymani J, Jouyban A. Efficacy of Analytical Technologies in Metabolomics Studies of the Gastrointestinal Cancers. Crit Rev Anal Chem 2021;:1-13. [PMID: 33757389 DOI: 10.1080/10408347.2021.1901646] [Reference Citation Analysis]
5 Ma B, Li Y, Ren Y. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer. Cancer Med 2020;9:335-49. [PMID: 31743579 DOI: 10.1002/cam4.2621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
6 Yue C, Yu C, Peng R, Wang J, Li G, Xu L. LINC00665/miR-379-5p/GRP78 regulates cisplatin sensitivity in gastric cancer by modulating endoplasmic reticulum stress. Cytotechnology 2021;73:413-22. [PMID: 34149174 DOI: 10.1007/s10616-021-00466-3] [Reference Citation Analysis]
7 Fisher BW, Jammula S, Wang S, Fluck M, Young K, Shabahang M, Blansfield J. Short-term Outcomes of Emergent Versus Elective Gastrectomy for Gastric Adenocarcinoma: A National Surgical Quality Improvement Program Study. Am Surg 2022;:31348221074232. [PMID: 35196884 DOI: 10.1177/00031348221074232] [Reference Citation Analysis]
8 Misumi Y, Nonaka K. Prevention and Management of Complications and Education in Endoscopic Submucosal Dissection. J Clin Med 2021;10:2511. [PMID: 34204078 DOI: 10.3390/jcm10112511] [Reference Citation Analysis]
9 Fisher BW, Fluck M, Young K, Shabahang M, Blansfield J, Arora TK. Urgent Surgery for Gastric Adenocarcinoma: A Study of the National Cancer Database. J Surg Res 2020;245:619-28. [PMID: 31522035 DOI: 10.1016/j.jss.2019.07.073] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
10 Cattelan L, Ghazawi FM, Le M, Lagacé F, Rahme E, Zubarev A, Sasseville D, Litvinov IV, Waschke KA, Netchiporouk E. Geographic and Socioeconomic Disparity of Gastric Cancer Patients in Canada. Curr Oncol 2021;28:2052-64. [PMID: 34071354 DOI: 10.3390/curroncol28030190] [Reference Citation Analysis]
11 Epistola RJ, Chao J. Systemic therapy for advanced gastroesophageal cancers: progress and pitfalls. Transl Gastroenterol Hepatol 2020;5:53. [PMID: 33073048 DOI: 10.21037/tgh.2020.01.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zeng W, Xing ZT, Tan MY, Wu YW, Zhang CY. Lidocaine suppresses the malignant behavior of gastric cancer cells via the c-Met/c-Src pathway. Exp Ther Med 2021;21:424. [PMID: 33747163 DOI: 10.3892/etm.2021.9868] [Reference Citation Analysis]
13 Van Cutsem E, Valderrama A, Bang YJ, Fuchs CS, Shitara K, Janjigian YY, Qin S, Larson TG, Shankaran V, Stein S, Norquist JM, Kher U, Shah S, Alsina M. Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study. ESMO Open 2021;6:100189. [PMID: 34371381 DOI: 10.1016/j.esmoop.2021.100189] [Reference Citation Analysis]
14 Abraham P, Wang L, Jiang Z, Gricar J, Tan H, Kelly RJ. Healthcare utilization and total costs of care among patients with advanced metastatic gastric and esophageal cancer. Future Oncol 2021;17:291-9. [PMID: 32996811 DOI: 10.2217/fon-2020-0516] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Kasochi C, Julius P, Mweemba I, Kayamba V. Human epidermal growth factor receptor 2 overexpression in gastric and gastroesophageal junction adenocarcinoma in patients seen at the University Teaching Hospital, Lusaka, Zambia. Afr Health Sci 2020;20:1857-64. [PMID: 34394249 DOI: 10.4314/ahs.v20i4.41] [Reference Citation Analysis]
16 Gong X, Zhang H. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer. J Clin Lab Anal 2020;34:e23268. [PMID: 32118318 DOI: 10.1002/jcla.23268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wang XQ, Terry PD, Li Y, Zhang Y, Kou WJ, Wang MX. Association of XPG rs2094258 polymorphism with gastric cancer prognosis. World J Gastroenterol 2019; 25(34): 5152-5161 [PMID: 31558863 DOI: 10.3748/wjg.v25.i34.5152] [Reference Citation Analysis]
18 Lin R, Zhao S, Su L, Chen X, Xu C, He Q, Zhuo C, Ye Y. A kinase-interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients. J Clin Lab Anal 2020;34:e23350. [PMID: 32672362 DOI: 10.1002/jcla.23350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Zhou X, Liu M, Ren Q, Zhu W, Wang Y, Chen H, Chen J. Oral and injectable Marsdenia tenacissima extract (MTE) as adjuvant therapy to chemotherapy for gastric cancer: a systematic review. BMC Complement Altern Med 2019;19:366. [PMID: 31830977 DOI: 10.1186/s12906-019-2779-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
20 Liu Z, Wu X, Tian Y, Zhang W, Qiao S, Xu W, Liu Y, Wang S. H. pylori infection induces CXCL8 expression and promotes gastric cancer progress through downregulating KLF4. Mol Carcinog 2021;60:524-37. [PMID: 34038586 DOI: 10.1002/mc.23309] [Reference Citation Analysis]
21 Shaibu Z, Chen Z, Mzee SAS, Theophilus A, Danbala IA. Effects of reconstruction techniques after proximal gastrectomy: a systematic review and meta-analysis. World J Surg Oncol 2020;18:171. [PMID: 32677956 DOI: 10.1186/s12957-020-01936-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Akbari M, Tabrizi R, Kardeh S, Lankarani KB. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis. PLoS One 2019;14:e0219865. [PMID: 31348819 DOI: 10.1371/journal.pone.0219865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
23 Hu J, Li P, Shi B, Tie J. Effects and Mechanisms of Saikosaponin D Improving the Sensitivity of Human Gastric Cancer Cells to Cisplatin. ACS Omega 2021;6:18745-55. [PMID: 34337214 DOI: 10.1021/acsomega.1c01795] [Reference Citation Analysis]
24 Biagioni A, Skalamera I, Peri S, Schiavone N, Cianchi F, Giommoni E, Magnelli L, Papucci L. Update on gastric cancer treatments and gene therapies. Cancer Metastasis Rev 2019;38:537-48. [PMID: 31486976 DOI: 10.1007/s10555-019-09803-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 20.5] [Reference Citation Analysis]
25 Liu J, Geng Z, Zhang Y, Alharbi SA, Shi Y. Sesquiterpenoid bilobalide inhibits gastric carcinoma cell growth and induces apoptosis both in vitro and in vivo models. J Biochem Mol Toxicol 2021;35:e22723. [PMID: 33511709 DOI: 10.1002/jbt.22723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Yu J, Zhao J, Zhang M, Guo J, Liu X, Liu L. Metabolomics studies in gastrointestinal cancer: a systematic review. Expert Rev Gastroenterol Hepatol 2020;14:9-25. [PMID: 31786962 DOI: 10.1080/17474124.2020.1700112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
27 Li S, Chen J, Wang Y, Zhou X, Zhu W. Moxibustion for the side effects of surgical therapy and chemotherapy in patients with gastric cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e21087. [PMID: 32702853 DOI: 10.1097/MD.0000000000021087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Xu M, Ren L, Fan J, Huang L, Zhou L, Li X, Ye X. Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6. Life Sci 2021;290:120266. [PMID: 34968467 DOI: 10.1016/j.lfs.2021.120266] [Reference Citation Analysis]
29 Mansoor W, Arkenau HT, Alsina M, Shitara K, Thuss-Patience P, Cuffe S, Dvorkin M, Park D, Ando T, Van Den Eynde M, Beretta GD, Zaniboni A, Doi T, Tabernero J, Ilson DH, Makris L, Benhadji KA, Van Cutsem E. Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study. Gastric Cancer 2021;24:970-7. [PMID: 33713215 DOI: 10.1007/s10120-021-01156-x] [Reference Citation Analysis]
30 Wang L, Du WQ, Xie M, Liu MR, Huo FC, Yang J, Pei DS. Jab1 promotes gastric cancer tumorigenesis via non-ubiquitin proteasomal degradation of p14ARF. Gastric Cancer 2020;23:1003-17. [PMID: 32458234 DOI: 10.1007/s10120-020-01087-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Hou Y, Xu Y, Wu D. ADAMTS12 acts as a tumor microenvironment related cancer promoter in gastric cancer. Sci Rep 2021;11:10996. [PMID: 34040054 DOI: 10.1038/s41598-021-90330-3] [Reference Citation Analysis]